Biomedical sciences

The Department of Biomedical Sciences manages the research activity in Biology, Medicine and Public Health. It provides technologies and services to both the public and the private area, with the purpose of promoting knowledge on the fundamental mechanism governing physiological and pathological aspects in living organism, starting from basic research in life sciences to the study of human diseases and of innovative therapeutic interventions. The ultimate aim is to explore new opportunities for ameliorating the health of mankind.

The fundamental activities regard oncology, neurodegenerative diseases, cardiovascular and pulmonary diseases, immunology and infectious diseases, epidemiology and health care research, Biology and biomedical technologies. In these areas, some technologies have been developed and they have found a wider use in the different benchmark areas: proteomics, pharmacogenomics, advanced calculus in bioinformatics and system biology, robotic systems for the limbs’ rehabilitation, molecular diagnostics and imaging. 

Download the Department brochure - Department video (Italian version).

Call for proposals: understanding the pathogenesis of Dravet Syndrome

Institutional area

Gruppo Famiglie Dravet Onlus is launching a Call for proposals to support a one year (12 months) basic or clinical research project aimed at understanding the pathogenesis of Dravet Syndrome.
The budget requested can be made up to €50,000 (fifty thousand Euros).
Full text of the Call and the submission guidelines are available here:
LoIs must be submitted at not later than May 5, 2017

The Chef's brain

Press release 03/03/2017

Researchers investigate, for the first time, whether the chef’s brain is different from general population. They report that chef-related expertise has shaped brain anatomy in a way to become faster in some motor and cognitive realms

The nano-revolution reaches the heart: the EU-funded project Cupido

News 11/04/2017

The EU-funded project Cupido, started in February 2017, proposes an innovative solution: the application of nanotechnologies to the cardiovascular field. Cupido aims to hit the core of the cardiovascular disease, developing inhalable nanoparticles that can deliver as simple as breathing a therapeutic directly to the diseased heart. Nanoparticles are extremely tiny, almost 1 million times smaller than a grain of sand in size and far too small to see with conventional microscopes

Blocking inflammation to reduce cognitive disabilities

Press release 04/04/2017

For the first time a study published in the prestigious journal eLife demonstrates the direct relationship between the cognitive impairments that characterize disorders of the development of the infant brain and inflammation that affects the synapses, i.e. the brain structures sorting information and signals to the whole body

Italian alpine glacier now accelerating after 7000 years

Press release 30/01/2017

Thanks to a 7000-year old ice core, the Idpa-Cnr and an international team have discovered that an alpine glacier is now accelerating due to atmospheric warming. The deepest part of the Mt. Ortles glacier (Eastern Italian Alps) has indeed started to move for the first time since the period of the Tyrolean Iceman. The study has been published in The Cryosphere

Nanocubes for early identification of Alzheimer's and Parkinson's

Press release 28/02/2017

The innovative method takes advantage of silver nanocrystals activated by laser, which allow a sensitive detection of molecular traces of neurodegenerative diseases. The method has been developed by a team, led by IFAC-CNR in Florence and including researchers from IMM-CNR of Catania, the University of Modena and Reggio Emilia and the Saratov National Research State University (Russia). The study was published in the ACS Nano journal

17th Congress of the European society for photobiology

Event from 04/09/2017 to 08/09/2017

The 17th congress of the European society for photobiology will be held in Pisa (Italy) under the aegis of Cnr, Pisa Cnr Campus and Pisa University and municipality

Medulloblastoma: a potential new therapy

Press release 16/01/2017

A preclinical study indicates a possible new therapy for medulloblastoma, the most common brain malignancy in childhood. The study, conducted by a group of researchers of the Institute of Cell Biology and Neurobiology of the National Research Council of Italy at the Santa Lucia Foundation in Rome, highlights the ability of chemokine Cxcl3 to completely inhibit the tumor. The research results are published in Frontiers in Pharmacology

The 'liquid biopsy': an innovative 3D technology

Press release 19/01/2017

Cnr-Isasi Researchers reveal an innovative possibility to identify sick cells in the blood stream, not visible by standard techniques. The result has been published in a Nature Publishing Group Journal Light: Science and Applications. The effectiveness of the technique has been demonstrated also for the recognition of possible oceans’ contaminants

Research highlight: Age are not important to T cells?

Institutional Area

The repertoire of gluten immuno-toxic peptides has been extensively characterized in children with Celiac Disease thanks to a collaboration between Australia and Italy.This study, using large gluten peptide library and blood samples from children with Celiac Disease after a wheat bread consumption, demonstrates that the T lymhocytes  from young celiacs recognize the same gluten peptides as T cells from adults with Celiac Disease. These findings have important implication for either novel therapeutic strategies, and for prevention of this worldwide spreading disease